Market Place
Sourcing Support
Artax Biopharma Raises $8 Million Ahead of Phase 2a Data Expected in Q4
06 Aug 2024 //
PR NEWSWIRE
Artax Announces First Patient Dosed in Phase 2a Trial Evaluating AX-158
13 Feb 2024 //
PR NEWSWIRE
Artax Granted Clinical Trial Authorization for AX-158 Phase 2a Psoriasis Study
09 Nov 2023 //
PR NEWSWIRE
Artax Biopharma Announces Positive Phase 1 Results for AX-158
01 Jun 2023 //
PR NEWSWIRE
Artax Biopharma Appoints Andre Hoekema, Ph.D., to Company`s Board of Directors
07 Mar 2023 //
PR NEWSWIRE
Artax Biopharma Expands Company`s Scientific Advisory Board
15 Nov 2022 //
PRNEWSWIRE
Artax Biopharma Closes Financing to Advance First-in-Class Oral Immunomodulator
11 May 2022 //
PRNEWSWIRE
Artax Announces First-in-Human Dosing in Phase 1 Trial for AX-158
15 Dec 2021 //
PRNEWSWIRE
Artax Biopharma Granted MHRA Clinical Trial Authorization for AX-158
13 Jul 2021 //
PRNEWSWIRE
Artax Announces Issuance of U.S. Composition of Matter Patent for AX-158
17 Sep 2020 //
PRNEWSWIRE
Artax Biopharma Announces the Formation of Scientific Advisory Board AX-158
24 Jun 2020 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.